Precision and simplicity in every setting: Our IP-10-based ELISA and lateral flow test empower healthcare providers with reliable, efficient, and accessible solutions for Tuberculosis diagnostic.
Tuberculosis remains one of the top 10 causes of death worldwide and a leading cause of death from a single infectious agent.
- In 2022, 10.6 million people fell ill with Tuberculosis (TB), and 1.6 million lost their lives.
- Latent TB affects approximately one-quarter of the global population, with individuals at risk of progressing to active TB.
- Early and accurate detection and treatment of TB is critical to breaking the chain of transmission and eliminating TB globally.
Our Mission: To support healthcare providers with innovative diagnostic tools that address the global TB challenge.
Three tubes two choices: Choose the diagnostic tool that fits your needs.
RIDA®TB Tubes
Only three blood collection tubes per patient for efficient and reliable T-cell stimulation.
- Only three induction tubes per patient
- ESAT-6 and CFP-10 as established and specific antigens
- IP-10 induction in just 16 hours minimizes waiting times.
- Vacuum blood collection tubes for direct blood collection
Exclusively compatible with RIDASCREEN® TB and RIDA® QUICK TB
RIDASCREEN® TB ELISA
- Up to 28 determinations per plate for medium- to high-throughput settings.
- IP-10 induction in just 16 hours minimizes waiting times.
- Includes all required reagents in one kit for seamless implementation.
- Compatible with manual and automated workflows to fit your lab’s needs.
RIDA® QUICK TB Lateral Flow Test
- Designed for decentralized testing in health care centers, field programs, and mobile units.
- One test cartridge per patient for straightforward handling and reduced errors.
- Results in just 15 minutes, allowing immediate decision-making.
- Up to 100 fold induction compared to IFN-y.
- Robust colloidal gold technology
- no need for fluorescence
- less sensitive to light exposure, ensuring reliability in all settings.
- Readout and result interpretation with RIDA®Q3 lateral flow reader
- Supports continuous loading — RIDA®Q3 stays unoccupied during incubation, allowing ongoing workflows.
Our solutions empower healthcare providers to tackle TB in all environments:
- RIDASCREEN® TB ELISA: Laboratory-based testing for medium- to high-throughput requirements.
- RIDA® QUICK TB Lateral Flow Test: Rapid, reliable testing for small sample volumes, resource-limited settings or mobile care programs.
Performance
Outstanding performance compared to QuantiFERON®-TB Gold Plus (QFT-Plus)
- Multicentric diagnostic study with 338 patients from 7 study centers in Germany and South Africa
85.2 % sensitivity in active TB patients vs 71.6 % QFT-Plus
Strong agreement between RIDASCREEN® TB and RIDA®QUICK TB
- Positive percent agreement 92,1 %
- Negative percent agreement 98,9 %
PPV and NPV with QTF-Plus
- Positive percent agreement 96.9 %, Negative percent agreement 86,9 % *
*negative percent agreement lower due to higher sensitivity of the RIDASCREEN® TB in clinically confirmed active TB patients